Investigation of the effect of administration period of edoxaban on the venous thromboembolism prophylaxis and the side effect

Investigation of the effect of administration period of edoxaban on the venous thromboembolism prophylaxis and the side effect - Effect of administration period of edoxaban on the VTA and the side effect

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012476

Enrollment

200

Registered

2013-12-03

Start date

2013-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fracture of proximal femur

Interventions

7-day Edoxaban administration 14-day Edoxaban administration

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients with fractures with proximal femur -Patients whom operation is performed witinh 7 days after fractures

Exclusion criteria

Exclusion criteria: Patinets -whose body weight is less than 40 kg -who have renal dysfunction -who is taking anti platelet agents -who is taking anticoagulants -whom anticoagulants is administrated before operation -whos has high risk of bleeding

Design outcomes

Primary

Measure	Time frame
To evaluuate the incidence of venous thromboembolism prophylaxis after administration of edoxaban at post-operative days 8 and 15	—

Countries

Japan

Contacts

Public ContactSang Yang Lee

Kobe University Hospital Department of Orthopaedic Surgery

sangyang@beige.plala.or.jp078-382-5985

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026